×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This symposium will be conducted in Japanese Language.
Click Here to View the Program in Japanese
We've closed online registration.
Onsite resistration is still available.
Program Committee
-
Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Hiroko Ebina, MBA, RPh Principal Writer I
Proscribe KK - Part of the ENVISION PHARMA GROUP, Japan -
Yuko Kojima, RPh Sr. Executive Director
Eli Lilly Japan K.K., Japan -
Miyoshi Masuda Senior Manager, Medical Writing, Clinical Development Administration
Astellas Pharma Inc., Japan -
Satoru Mogami, MSc Regulatory Affairs
Pfizer R&D Japan, Japan -
Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Tomoko Okudaira Deputy Review Director, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Naoko Tejima Group Manager, Regulatory Writing & Operations Group, Regulatory Affairs
Astellas Amgen Biopharma, Japan
Have an account?